DarioHealth Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for DarioHealth Corp. (DRIO) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-42.75-59.43-62.19-76.76-29.45-17.74-17.80
Depreciation & Amortization7.434.994.724.460.190.180.21
Stock Based Compensation15.8019.7016.9824.9711.100.000.00
Change in Working Capital-2.474.07-10.90-3.081.54-0.602.37
Change in Accounts Receivable1.683.26-5.11-0.350.550.000.00
Change in Inventory0.312.89-1.73-2.23-0.880.000.00
Change in Accounts Payable-0.50-1.19-4.101.080.820.000.00
Change in Other Working Capital-3.81-0.573.56-1.42-0.080.000.00
Other Operating Activities-16.570.293.5624.929.982.430.00
Net Cash from Operating Activities-38.56-30.38-47.85-50.41-17.74-15.73-11.47
Investing Activities
Capital Expenditures-0.14-0.58-0.57-0.260.120.10-0.07
Acquisitions-8.80-5.000.00-7.470.000.000.00
Purchases of Investments0.000.040.000.000.000.000.00
Sales/Maturities of Investments0.005.03-0.13-0.40-1.50-0.020.00
Other Investing Activities0.000.000.000.000.00-0.020.00
Net Cash from Investing Activities-8.93-0.55-0.57-8.13-1.62-0.11-0.07
Financing Activities
Debt Repayment0.00-27.830.000.000.000.000.00
Common Stock Issued0.001.6138.2965.7727.5525.2518.74
Common Stock Repurchased0.000.00-0.130.000.000.000.00
Other Financing Activities38.530.000.000.000.000.000.00
Net Cash from Financing Activities38.5318.2561.9465.7727.5525.2518.74
Summary
Effect of Forex Changes on Cash-0.070.000.000.000.000.000.00
Net Change in Cash-9.03-12.6713.527.228.199.417.20
Cash at Beginning of Period36.8049.4735.9528.7320.5411.133.93
Cash at End of Period27.7636.8049.4735.9528.7320.5411.13
Free Cash Flow-38.70-30.96-48.42-50.67-17.85-15.82-11.54
Supplemental Disclosures
Interest Paid0.000.001.880.000.000.000.00